Thrivent Financial For Lutherans Glaukos Corp Transaction History

Thrivent Financial For Lutherans

$45.7 Billion
Q2 2025

A detailed history of Thrivent Financial For Lutherans transactions in Glaukos Corp stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 42,017 shares of GKOS stock, worth $3.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

42,017

Previous 40,499 3.75%

Holding current value

$3.49 Million

Previous $3.99 Million 8.88%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 26, 2025	BUY	$82.27 - $103.29 $124,885 - $156,794	1,518 Added 3.75%	42,017 $4.34 Million
Q1 2025 Aug 26, 2025	BUY	$96.6 - $161.22 $3.91 Million - $6.53 Million	40,499 New	40,499 $3.99 Million
Q4 2024 Feb 10, 2025	SELL	$126.42 - $152.67 $67,508 - $81,525	-534 Reduced 1.24%	42,618 $6.39 Million
Q3 2024 Nov 07, 2024	BUY	$113.62 - $135.39 $152,137 - $181,287	1,339 Added 3.2%	43,152 $5.62 Million
Q2 2024 Aug 13, 2024	SELL	$89.48 - $118.35 $46,708 - $61,778	-522 Reduced 1.23%	41,813 $4.95 Million
Q1 2024 May 14, 2024	SELL	$76.4 - $96.33 $82,359 - $103,843	-1,078 Reduced 2.48%	42,335 $3.99 Million
Q4 2023 Feb 14, 2024	SELL	$59.53 - $85.11 $65,006 - $92,940	-1,092 Reduced 2.45%	43,413 $3.45 Million
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $111,667 - $127,572	-1,613 Reduced 3.5%	44,505 $3.35 Million
Q2 2023 Aug 14, 2023	SELL	$45.44 - $71.21 $52,528 - $82,318	-1,156 Reduced 2.45%	46,118 $3.28 Million
Q1 2023 May 17, 2023	SELL	$43.88 - $52.48 $72,709 - $86,959	-1,657 Reduced 3.39%	47,274 $2.37 Million
Q4 2022 Feb 08, 2023	SELL	$40.82 - $57.75 $11,062 - $15,650	-271 Reduced 0.55%	48,931 $2.14 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $126,374 - $157,806	2,698 Added 5.8%	49,202 $2.62 Million
Q2 2022 Aug 16, 2022	BUY	$34.86 - $63.77 $290,453 - $531,331	8,332 Added 21.83%	46,504 $2.11 Million
Q1 2022 May 13, 2022	BUY	$44.33 - $57.82 $531 - $693	12 Added 0.03%	38,172 $2.21 Million
Q4 2021 Feb 16, 2022	BUY	$40.27 - $56.99 $21,101 - $29,862	524 Added 1.39%	38,160 $1.7 Million
Q3 2021 Nov 15, 2021	SELL	$47.43 - $84.23 $9,438 - $16,761	-199 Reduced 0.53%	37,636 $1.81 Million
Q2 2021 Aug 19, 2021	BUY	$73.06 - $97.7 $16,292 - $21,787	223 Added 0.59%	37,835 $3.21 Million
Q1 2021 May 17, 2021	BUY	$70.43 - $97.42 $27,960 - $38,675	397 Added 1.07%	37,612 $3.16 Million
Q4 2020 Feb 16, 2021	BUY	$48.9 - $75.26 $8,361 - $12,869	171 Added 0.46%	37,215 $2.8 Million
Q3 2020 Nov 10, 2020	BUY	$37.23 - $50.97 $138,681 - $189,863	3,725 Added 11.18%	37,044 $1.83 Million
Q2 2020 Aug 12, 2020	BUY	$28.78 - $46.83 $18,419 - $29,971	640 Added 1.96%	33,319 $1.28 Million
Q1 2020 May 15, 2020	BUY	$25.53 - $70.14 $834,294 - $2.29 Million	32,679 New	32,679 $1.01 Million

Others Institutions Holding GKOS

# of Institutions

334

Shares Held

54.4M

Call Options Held

259K

Put Options Held

481K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $3.95B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Glaukos Corp Transaction History